Treatment outcome in infant acute lymphoblastic leukemia

被引：0

作者：

Ferster, A ^{[1
]}

Benoit, Y ^{[1
]}

Francotte, N ^{[1
]}

Dresse, MF ^{[1
]}

Uyttebroeck, A ^{[1
]}

Plouvier, E ^{[1
]}

Thyss, A ^{[1
]}

Lutz, P ^{[1
]}

Marguerite, G ^{[1
]}

Behar, C ^{[1
]}

Mazingue, F ^{[1
]}

Boutard, P ^{[1
]}

Millot, F ^{[1
]}

Rialland, X ^{[1
]}

Mechinaud, F ^{[1
]}

Norton, L ^{[1
]}

Robert, A ^{[1
]}

Otten, J ^{[1
]}

Vilmer, E ^{[1
]}

Philippe, N ^{[1
]}

Waterkeyn, C ^{[1
]}

Suciu, S ^{[1
]}

机构：

[1] Hop Univ Enfants Reine Fabiola, EORTC, Children Leukemia Cooperat Grp, Brussels, Belgium

来源：

BLOOD | 2000年 / 95卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2729 / 2730

页数：2

共 50 条

[31] ACUTE LYMPHOBLASTIC LEUKEMIA - TREATMENT
FREI, E
SALLAN, SE
CANCER, 1978, 42 (02) : 828 - 838
[32] TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
BURCHENAL, JH
TAN, CTC
DOWLING, MD
ANNUAL REVIEW OF MEDICINE, 1972, 23 (05): : 77 - +
[33] TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
SINKS, LF
ARCHIVES OF DISEASE IN CHILDHOOD, 1972, 47 (255) : 811 - &
[34] Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment
R Jung
U Jacobs
M Krumbholz
T Langer
T Keller
P De Lorenzo
M G Valsecchi
V H J van der Velden
A Moericke
M Stanulla
A Teigler-Schlegel
E R Panzer-Gruemayer
J J M van Dongen
M Schrappe
M L den Boer
R Pieters
W Rascher
M Metzler
Leukemia, 2010, 24 : 903 - 907
[35] Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment
Jung, R.
Jacobs, U.
Krumbholz, M.
Langer, T.
Keller, T.
De Lorenzo, P.
Valsecchi, M. G.
van der Velden, V. H. J.
Moericke, A.
Stanulla, M.
Teigler-Schlegel, A.
Panzer-Gruemayer, E. R.
van Dongen, J. J. M.
Schrappe, M.
den Boer, M. L.
Pieters, R.
Rascher, W.
Metzler, M.
LEUKEMIA, 2010, 24 (04) : 903 - 907
[36] Trends in management of acute lymphoblastic leukemia: Influence of insurance based healthcare and treatment compliance on the outcome of adolescents and adults with acute lymphoblastic leukemia
Arigela, Ravi Sankar
Gundeti, Sadashivudu
Ganta, Ranga Raman
Nasaka, Srividhya
Linga, Vijay Gandhi
Maddali, Lakshmi Srinivas
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2016, 37 (01) : 32 - 37
[37] Erratum: Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
E M C Driessen
P de Lorenzo
M Campbell
M Felice
A Ferster
I Hann
A Vora
L Hovi
G Escherich
C K Li
G Mann
T Leblanc
F Locatelli
A Biondi
J Rubnitz
M Schrappe
L Silverman
J Stary
R Suppiah
T Szczepanski
M Valsecchi
R Pieters
Leukemia, 2017, 31 : 2854 - 2854
[38] Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
Rocha, JCC
Cheng, C
Liu, W
Kishi, S
Das, S
Cook, EH
Sandlund, JT
Rubnitz, J
Ribeiro, R
Campana, D
Pui, CH
Evans, WE
Relling, MV
BLOOD, 2005, 105 (12) : 4752 - 4758
[39] Race and outcome in childhood acute lymphoblastic leukemia
Carroll, WL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15): : 2061 - 2063
[40] Molecular predictors of outcome in acute lymphoblastic leukemia
Campana, D.
Flotho, Ch.
Coustan-Smith, E.
Pui, C-H.
Downing, J. R.
ANNALS OF HEMATOLOGY, 2008, 87 : S40 - S42

← 1 2 3 4 5 →